SstI Polymorphism of the Apolipoprotein CIII Gene in Iranian Hyperlipidemic Patients: A Study in Semnan Province

被引:0
作者
Bandegi, Ahmad Reza [1 ]
Firoozrai, Mohsen [2 ]
Eidgahi, Mohammad Reza Akbari [3 ]
Kokhaei, Parviz [4 ,5 ]
机构
[1] Semnan Univ Med Sci, Fac Med, Dept Biochem, Semnan, Iran
[2] Iran Univ Med Sci, Fac Med, Dept Biochem, Tehran, Iran
[3] Semnan Univ Med Sci, Biotechnol Res Ctr, Semnan, Iran
[4] Karolinska Univ Hosp Solna, CCK, Immune & Gene Therapy Lab, Stockholm, Sweden
[5] Semnan Univ Med Sci, Fac Med, Dept Immunol, Semnan, Iran
关键词
Apolipoprotein C-III; Genetic; Hyperlipidemia; Iran; PCR; Polymorphism; LIPOPROTEIN-LIPASE GENE; C-III; LIPID-LEVELS; APO-CIII; A-I; INCREASED RISK; ASSOCIATION; HYPERTRIGLYCERIDEMIA; CLUSTER; CHOLESTEROL;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective(s) The Sst-I polymorphic site on the 3' untranslated region of the apo CIII gene, has been previously reported to be associated with hypertriglyceridemia. The aim of the present. study was to explore the association between Sst-I polymorphism with plasma lipid and lipoprotein levels in hyperlipidemic (HLP) patients from Semnan province, Iran. Materials and Methods Genomic DNA was prepared from 76 patients with HLP and 75 matched healthy subjects. DNA samples were amplified by polymerase chain reaction. The samples were analyzed by restriction fragment length polymorphism (RFLP) method using SstI enzyme. Results The genotype and allelic frequencies for this polymorphism were significantly different between HLP and normolipidemic groups (P< 0.002). Plasma triglyceride (TG) level was higher in both groups, in S2S2 genotype was more than in the SIS1 and 51S2 genotypes, however, there was no significant difference in comparison with the control group. Subjects with S1S2 + S2S2 genotypes in compare to S1S1 genotype had odd ratio of 2.8(95% CI: 1.41-5.56, P< 0.003) for developing hypertriglyceridemia. Conclusion The results showed that the presence of rare S2 allele was associated with change in TG level in the selected population.
引用
收藏
页码:506 / 513
页数:8
相关论文
共 38 条
[1]   Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000 [J].
Arai, H ;
Yamamoto, A ;
Matsuzawa, Y ;
Saito, Y ;
Yamada, N ;
Oikawa, S ;
Mabuchi, H ;
Teramoto, T ;
Sasaki, J ;
Nakaya, N ;
Itakura, H ;
Ishikawa, Y ;
Ouchi, Y ;
Horibe, H ;
Egashira, T ;
Hattori, H ;
Shirahashi, N ;
Kita, T .
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2005, 12 (05) :240-250
[2]   Serum lipid levels in an Iranian adults population: Tehran lipid and glucose study [J].
Azizi, F ;
Rahmani, M ;
Ghanbarian, A ;
Emami, H ;
Salehi, P ;
Mirmiran, P ;
Sarbazi, N .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2003, 18 (04) :311-319
[3]   Interaction between the APOC3 gene promoter polymorphisms, saturated fat intake and plasma lipoproteins [J].
Brown, S ;
Ordovás, JM ;
Campos, H .
ATHEROSCLEROSIS, 2003, 170 (02) :307-313
[4]   Apolipoprotein AI and CIII gene polymorphisms and their association with lipid levels in Italian, Greek and Anglo-Irish populations of Australia [J].
Buzza, M ;
Fripp, Y ;
Mitchell, RJ .
ANNALS OF HUMAN BIOLOGY, 2001, 28 (05) :481-490
[5]   Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians [J].
Chhabra, S ;
Narang, R ;
Krishnan, L ;
Vasisht, S ;
Agarwal, DP ;
Srivastava, LM ;
Manchanda, SC ;
Das, N .
BMC GENETICS, 2002, 3 (1)
[6]  
DallingaThie GM, 1996, J LIPID RES, V37, P136
[7]   Complex genetic contribution of the apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia - Identification of different susceptibility haplotypes [J].
DallingaThie, GM ;
Trip, MV ;
Rotter, JI ;
Cantor, RM ;
Bu, XD ;
Lusis, AJ ;
deBruin, TWA .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (05) :953-961
[8]   Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France [J].
Dallongeville, J ;
Meirhaeghe, A ;
Cottel, D ;
Fruchart, JC ;
Amouyel, P ;
Helbecque, N .
ATHEROSCLEROSIS, 2000, 150 (01) :149-157
[9]   AN APOLIPOPROTEIN CIII HAPLOTYPE PROTECTIVE AGAINST HYPERTRIGLYCERIDEMIA IS SPECIFIED BY PROMOTER AND 3' UNTRANSLATED REGION POLYMORPHISMS [J].
DAMMERMAN, M ;
SANDKUIJL, LA ;
HALAAS, JL ;
CHUNG, W ;
BRESLOW, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) :4562-4566
[10]   Structure and dynamics of human apolipoprotein CIII [J].
Gangabadage, Chinthaka Saneth ;
Zdunek, Janusz ;
Tessari, Marco ;
Nilsson, Solveig ;
Olivecrona, Gunilla ;
Wijmenga, Sybren Sipke .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (25) :17416-17427